J9065 HCPCS code: Injection, cladribine, per 1 mg
J9065 is the HCPCS Level II code for injection, cladribine, per 1 mg. In 2024 Medicare paid an average of $11.61 per service for J9065 across 8,061 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 100 per day on DME suppliers. Medicare volume fell 19% from 2022 to 2024 (9,980 to 8,061 services). In 2024, about 259 clinicians billed Medicare for J9065 for 108 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1995-01-01 |
| Last action effective | 1997-01-01 |
Who bills J9065 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 259 |
| Medicare beneficiaries | 108 |
| States with claims | 2 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9065, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 9,980 | 119 | $18.95 | $15.06 |
| 2023 | 10,635 | 133 | $18.97 | $15.07 |
| 2024 | 8,061 | 108 | $14.57 | $11.61 |
States with the most J9065 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,230 | $11.85 |
| Texas | 838 | $11.84 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 100 | Prescribing Information |
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 100 | Prescribing Information |
What changed for J9065
- 1995-01-01: J9065 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9065?
J9065 is the HCPCS Level II code for injection, cladribine, per 1 mg. Short descriptor: "Inj cladribine per 1 mg".
How much does Medicare pay for J9065?
In 2024, the average Medicare payment was $11.61 per service (average allowed $14.57).
Does Medicare cover J9065?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J9065 can be billed per day?
100 on DME suppliers; 100 on outpatient hospital claims; 100 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9003 — Leuprolide injectable (camcevi etm), 1 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9065
- Watch J9065 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9065
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.